segment reported $88 million of operating income for the fourth quarter of 2018 compared to $80 million for the fourth quarter of 2017.
With Rating Outlook Stable, the 'BBB-' rating is supported by VLP
's low leverage, strong distribution coverage and stable cash flows.
GeoVax's vaccine platform supports in vivo production of non-infectious VLPs
from the cells of the very person receiving the vaccine, mimicking a natural infection and effectively stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection.
The self-assembly of the viral particle needs a single viral capsid protein To make VLP
The Xtralis Vesda series occupies the same mounting footprint, pipe, conduit and electrical connector positioning as Vesda VLP
for the seamless retrofit of the installed base.
, small volumes (1-2 mL) of unfixed water sample were filtered through 25-mm diameter Anodisc membranes (Whatman International Ltd, Maidstone, England).
According to Cadila, utilization of the VLP
know-how considerably speeds up the overall production process.
In the first surgery, reduction and fixation were achieved with a MODE VLP
for proximal placement (Medical Dynamic Marketing Inc., Tokyo, Japan), used as a buttress plate (Figure2(a)).
offers a broad variety of business and transactional services to companies, financial institutions, investors and universities throughout the nation.
The general partner of Texas-based petroleum products assets owner Valero Energy Partners LP (NYSE: VLP
) has approved the partnership's acquisition of the Louisiana-based Meraux and Texas-based Three Rivers Terminal Services Business from a subsidiary of Texas-based petroleum refining company Valero Energy Corp.
The panel featured: Laura Cox Kaplan, principal-in-charge of government, regulatory affairs and public policy at PwC; Maria Pasquale, senior vice president legal and deputy general counsel, Celgene; Jane Imperatore, partner, VLP
Law Group; and Susan Smith Blakely, author of "Best Friends at the Bar."
Whereas traditional vaccines are typically made from either killed viruses or from weakened live ones, the experimental vaccine used in the trial is a different type: a virus-like particle (VLP
) vaccine, which contains the outer shell proteins of a virus without any of the material the virus needs to replicate inside cells.